% IMPORTANT: The following is UTF-8 encoded. This means that in the presence % of non-ASCII characters, it will not work with BibTeX 0.99 or older. % Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or % “biber”. @ARTICLE{Mihyar:995586, author = {Mihyar, Rahaf and Azadkhah Shalmani, Armin and Wildt, Viktor and Sheybanifard, Maryam and Wang, Alec and May, Jan-Niklas and Shahzad, Saba and Buhl, Eva Miriam and Rütten, Stephan and Behrens, Diana and Walther, Wolfgang and Tiboni, Mattia and Casettari, Luca and Buyel, Johannes F. and Rijcken, Cristianne J. F. and Hennink, Wim E. and von Stillfried, Saskia and Kiessling, Fabian and Shi, Yang and Metselaar, Josbert M. and Lammers, Twan and Peña, Quim}, title = {{M}icrofluidic formulation, cryoprotection and long-term stability of paclitaxel-loaded π electron-stabilized polymeric micelles}, journal = {Journal of controlled release}, volume = {375}, issn = {1873-4995}, address = {New York, NY [u.a.]}, publisher = {Elsevier}, reportid = {RWTH-2024-10007}, pages = {614-626}, year = {2024}, month = {Feb}, date = {2024-02-14}, organization = {15. Spanish-Portuguese Conference on Controlled Drug Delivery – New Horizons, Lisbon (Portugal), 14 Feb 2024 - 16 Feb 2024}, cin = {811003-3 ; 924210 / 922910 / 025000}, ddc = {610}, cid = {$I:(DE-82)811003-3_20140620$ / $I:(DE-82)528001-2_20140620$ / $I:(DE-82)025000_20140620$}, pnm = {OAPKF - Open-Access-Publikation mit Unterstützung der RWTH Aachen University (021000-OAPKF) / BMBF 16GW0319K - Wirkstofftransport: Paclitaxel-beladene polymere Mizellen (Pizellen) für die Behandlung von Triple-negativem Brustkrebs (PP-TNBC) - Von der Synthese über Wirksamkeit in die Klinik (16GW0319K) / GRK 2375 - GRK 2375: Tumor-Targeted Drug Delivery (331065168) / DFG project G:(GEPRIS)213555243 - SFB 1066: Nanodimensionale polymere Therapeutika für die Tumortherapie (213555243) / Meta-Targeting - Macro-Nanomedicine to Treat Metastatic Cancer (864121) / DFG project G:(GEPRIS)444727588 - Penetrationsfördernde polymere Mizellen für die Behandlung fibrotischer Tumore (444727588)}, pid = {G:(DE-82)021000-OAPKF / G:(BMBF)16GW0319K / G:(GEPRIS)331065168 / G:(GEPRIS)213555243 / G:(EU-Grant)864121 / G:(GEPRIS)444727588}, typ = {PUB:(DE-HGF)16 / PUB:(DE-HGF)8}, UT = {WOS:001322620700001}, pubmed = {pmid:39316925}, doi = {10.1016/j.jconrel.2024.08.041}, url = {https://publications.rwth-aachen.de/record/995586}, }